Physician profile
Sunil Kumar
NPI 1407184377
$164,983.48
in general payments reported to CMS, 2019-2025
24 companies · $9,279 in 2025
The $9,279 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,439 · 2020: $14K · 2021: $35K · 2022: $31K · 2023: $34K · 2024: $39K · 2025: $9,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $5,885 · Honoraria: $1,500 · Travel and Lodging: $1,451 · Education: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,500.00 |
| Food and Beverage | $5,885.38 |
| Honoraria | $1,500.00 |
| Travel and Lodging | $1,450.87 |
| Education | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $84,750.00 | 2020-2024 | Carto 3 |
| Medtronic, INC. | $59,703.38 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Affera Mapping System |
| Abbott Laboratories | $5,867.99 | 2019-2025 | Amplatzer Amulet, Aveir, Confirm Rx |
| Biosense Webster, INC. | $5,227.91 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Altathera Pharmaceuticals LLC | $4,278.30 | 2023-2025 | Sotalol Hydrochloride |
| Biotronik INC. | $1,200.00 | 2021 | |
| Impulse Dynamics (USA) INC. | $704.84 | 2022-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $657.67 | 2019-2025 | Watchman Flx, Farapulse |
| Cvrx, INC. | $493.97 | 2024-2025 | Barostim Neo System |
| Terumo Medical Corporation | $350.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $334.13 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $312.08 | 2019-2020 | |
| Abiomed | $283.61 | 2024-2025 | Impella |
| Pfizer INC. | $254.35 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $111.01 | 2022-2023 | Tagrisso |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $99.95 | 2021 | |
| Novartis Pharmaceuticals Corporation | $75.92 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $73.32 | 2019-2020 | |
| Cardiva Medical, INC. | $66.65 | 2019 | |
| Merck Sharp & Dohme LLC | $60.79 | 2022-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.11 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $18.16 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $17.92 | 2025 | Camzyos |
| Portola Pharmaceuticals, LLC | $17.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.